A Boom in Listings
China's A-share IPO market delivered its healthiest first half in years. A total of 71 companies completed listings on mainland exchanges between January and June 2026, raising a combined over 705 billion yuan — a figure that signals renewed investor appetite and a more selective but robust pipeline of quality issuers.
Quality Over Quantity
The "healthy" characterisation by market observers reflects not just the capital raised, but the composition of issuers. High-tech sectors — semiconductor design, AI software, biotech and new materials — dominated the new listings, aligning with Beijing's strategic priority on self-reliance in critical technologies.
Hong Kong Recovery
Hong Kong's IPO market also rebounded in H1 2026, with dual-market listings (Shanghai-Hong Kong and Shenzhen-Hong Kong connect flows) rising meaningfully. CICC (China International Capital Corporation) retained its position as the top bookrunner across both A-share and Hong Kong markets, followed by CITIC Securities and China Merchants Bank Capital.
STAR Market Performance
The ChiNext and STAR (Science, Technology & Innovation) board indices have been particular beneficiaries of the IPO pipeline. The STAR Market Index hit 2,305 points — a multi-year high — as tech listings attracted strong institutional and retail interest. Average first-day "stagger" rates (the gain from issue price to closing on listing day) remained healthy at around 150–200% for qualifying tech names.
Regulatory Backdrop
The China Securities Regulatory Commission (CSRC) has maintained a measured approach — encouraging listings in strategic sectors while enforcing stricter disclosure and governance standards. The goal is a sustainable pipeline rather than the speculative excess of earlier cycles.